Projects

Prospective evaluation of etiological factors, trajectory of comorbidities and, efficacy and safety of various therapeutic agents among Indian women with Polycystic ovary syndrome (PCOS)” A Multicentric ICMR-PCOS Cohort Study Phase II

Project Description

Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation. Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.

Project Duration

2023 - 2026

Project Lead

Dr. Ganapathi

Authors

Dr. Ganapathi Dr. Vageesh Dr.Annamma Thomas Dr. Belinda Dr Sonali Appaiah

Project Status

ongoing

Project Type

ICMR